Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000689893 | SCV000817563 | uncertain significance | Developmental and epileptic encephalopathy, 37 | 2024-04-02 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 253 of the FRRS1L protein (p.Val253Ile). This variant is present in population databases (rs753224453, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with FRRS1L-related conditions. ClinVar contains an entry for this variant (Variation ID: 569298). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV000689893 | SCV001525526 | uncertain significance | Developmental and epileptic encephalopathy, 37 | 2019-06-07 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ce |
RCV003432735 | SCV004158547 | uncertain significance | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | FRRS1L: PM2 |